Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 62 peer-reviewed journal articles Updated
Endocrinology · Glycogen Storage Disease Type I

Understanding Your GSD I Diagnosis

At a Glance

Glycogen Storage Disease Type I (GSD I) is a rare condition where the liver cannot release stored sugar, causing severe hypoglycemia. It is highly manageable through precise dietary control, frequent feedings, and uncooked cornstarch, allowing children to live healthy, active, independent lives.

Receiving a diagnosis of Glycogen Storage Disease Type I (GSD I), also known as von Gierke disease, can feel overwhelming [1]. It is a rare condition, affecting approximately 1 in every 100,000 newborns [2]. While the initial news often brings a sense of panic—particularly regarding the risk of severe hypoglycemia (dangerously low blood sugar) and the intensity of the required feeding schedule—it is important to know that this is a manageable condition with a well-established path forward [3][4].

This guide is designed to help you navigate your diagnosis, understand your treatment, and build a care team. Please use the links below to explore specific topics in detail.

01

Recognizing GSD I Symptoms & Hypoglycemia

Learn the early signs of Glycogen Storage Disease Type 1 (GSD 1) in children. Understand silent hypoglycemia, enlarged liver, bruising, and other key symptoms.

02

How GSD I Works in the Body

Learn how Glycogen Storage Disease Type 1 (GSD I) works in the body. Understand the missing G6Pase enzyme, genetic causes, and why metabolic changes occur.

03

GSD Ia vs GSD Ib: Understanding the Differences

Learn the key differences between Glycogen Storage Disease (GSD) types Ia and Ib. Understand how symptoms, immune system impacts, and treatments vary.

04

Your Treatment Plan: Cornstarch and Metabolic Control

Learn about the Glycogen Storage Disease Type 1 (GSD I) treatment plan. Understand how uncooked cornstarch, dietary restrictions, and CGMs manage blood sugar.

05

Assembling Your GSD Care Team

Learn how to build a care team for Glycogen Storage Disease Type 1. Understand required specialists, metabolic center evaluation, and critical ER protocols.

06

Long-Term Monitoring: Liver, Kidneys, and Beyond

Learn about long-term monitoring for Glycogen Storage Disease Type I (GSD I). Understand liver ultrasounds, kidney function tests, and bone health screenings.

Understanding GSD I

In a typical body, the liver acts like a battery. When you eat, it stores extra energy as glycogen. When you haven’t eaten for a while, the liver converts that glycogen back into glucose (sugar) to keep your energy levels steady. In GSD I, the “switch” that allows the liver to release this sugar is missing or broken [1]. Because the body cannot release stored sugar, blood sugar levels can drop very quickly during periods of fasting [5].

Three Stabilizing Facts for Families

While the diagnosis is serious, three key facts can help provide a sense of stability for your family:

  1. Dietary Control is Highly Effective: The primary treatment for GSD I is not surgery or intense medication, but precise nutrition [3]. By providing a steady source of glucose through frequent feedings and the use of uncooked cornstarch—which acts as a slow-release “time-release” sugar—you can keep your child’s metabolic levels stable [6][7].
  2. Technology Has Made Management Safer: In the past, parents had to rely solely on finger-stick tests. Today, Continuous Glucose Monitors (CGMs) provide real-time data and alerts if blood sugar begins to drop, offering an extra layer of safety and peace of mind, especially overnight [8][9].
  3. Fulfilling Adult Lives are the Standard: With modern management, the outlook for children with GSD I has changed dramatically. Children diagnosed today are expected to grow into adults who attend college, have careers, and live independently [10].

Subtypes: GSD Ia vs. GSD Ib

Your doctor will determine if your child has GSD Ia or GSD Ib through genetic testing [11].

  • GSD Ia: The most common form, primarily affecting blood sugar levels and liver/kidney health [1].
  • GSD Ib: Includes the same blood sugar challenges but also involves neutropenia (a low count of certain white blood cells), which can make children more prone to infections and inflammatory bowel issues [12][13].

The Path Ahead: Long-Term Outlook

The goal of treatment is to maintain “good metabolic control” [4]. This means keeping blood sugar, lactate, and other markers within a healthy range to allow the body to grow normally and to protect organs over time [14][15].

While strict adherence to the diet is the foundation of care, researchers and doctors have reached a strong consensus on the standard of care [3]. Regular monitoring of the liver and kidneys is a standard part of the routine to catch and manage any potential complications early [16][17]. As research continues to advance—including the development of extended-release cornstarch and new medications—the burden of daily management continues to improve, allowing children with GSD I to lead active, vibrant lives [7][18].

Common questions in this guide

How is Glycogen Storage Disease Type I treated?
The primary treatment for GSD I is precise dietary management rather than medication or surgery. By providing a steady source of glucose through frequent feedings and uncooked cornstarch, blood sugar levels can be kept safely stable.
What is the difference between GSD Ia and GSD Ib?
GSD Ia primarily affects blood sugar levels, the liver, and kidneys. GSD Ib causes the same blood sugar challenges but also includes neutropenia, which is a low white blood cell count that increases the risk of infections and inflammatory bowel issues.
Why do we need a Continuous Glucose Monitor (CGM) for GSD I?
A Continuous Glucose Monitor provides real-time tracking of blood sugar levels without relying solely on painful finger-stick tests. It offers an extra layer of safety by alerting you if blood sugar begins to drop, which is especially important for monitoring your child overnight.
Can children with GSD I live normal adult lives?
Yes. With modern management and good metabolic control, children diagnosed with GSD I today are expected to grow into adults who attend college, have careers, and live fully independent lives.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is our child's diagnosis GSD Ia or GSD Ib, and how does that subtype change their specific care plan?
  2. 2.What is the maximum 'safe fasting time' our child can currently tolerate between feedings?
  3. 3.How will we know if our child is in 'good metabolic control,' and which biomarkers (like lactate or alanine) will you be monitoring?
  4. 4.Can you recommend a metabolic dietitian who has specific experience managing GSD I?
  5. 5.Are we candidates for a Continuous Glucose Monitor (CGM) to help manage overnight blood sugar levels?
  6. 6.What is the long-term screening schedule for monitoring our child's liver and kidney health?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I.

    Sato T, Inokuchi M, Nakano S, et al.

    Radiology case reports 2023; (18(1)):91-93 doi:10.1016/j.radcr.2022.09.084.

    PMID: 36324837
  2. 2

    Systematic literature review of the epidemiology of glycogen storage disease type 1a.

    Zelei T, Kovács S, Finn P, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(9)):809-817 doi:10.1515/jpem-2023-0127.

    PMID: 37615591
  3. 3

    Glucose-6 Phosphate, A Central Hub for Liver Carbohydrate Metabolism.

    Rajas F, Gautier-Stein A, Mithieux G

    Metabolites 2019; (9(12)) doi:10.3390/metabo9120282.

    PMID: 31756997
  4. 4

    Genome editing using Staphylococcus aureus Cas9 in a canine model of glycogen storage disease Ia.

    Arnson B, Kang HR, Brooks ED, et al.

    Molecular therapy. Methods & clinical development 2023; (29()):108-119 doi:10.1016/j.omtm.2023.03.001.

    PMID: 37021039
  5. 5

    Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients.

    Sperb-Ludwig F, Pinheiro FC, Bettio Soares M, et al.

    Molecular genetics & genomic medicine 2019; (7(11)):e877 doi:10.1002/mgg3.877.

    PMID: 31508908
  6. 6

    Investigation and management of the hepatic glycogen storage diseases.

    Bhattacharya K

    Translational pediatrics 2015; (4(3)):240-8 doi:10.3978/j.issn.2224-4336.2015.04.07.

    PMID: 26835382
  7. 7

    Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.

    Ross KM, Brown LM, Corrado MM, et al.

    JIMD reports 2016; (26()):85-90 doi:10.1007/8904_2015_488.

    PMID: 26303612
  8. 8

    Role of continuous glucose monitoring in the management of glycogen storage disorders.

    Herbert M, Pendyal S, Rairikar M, et al.

    Journal of inherited metabolic disease 2018; (41(6)):917-927 doi:10.1007/s10545-018-0200-5.

    PMID: 29802555
  9. 9

    Hypoglycaemic Unawareness in a Glycogen Storage Disorder Patient: A Case Report and Review of the Literature.

    Alkundi A, Momoh R

    Cureus 2025; (17(4)):e81805 doi:10.7759/cureus.81805.

    PMID: 40330337
  10. 10

    Impact of glycogen storage disease type I on adult daily life: a survey.

    Garbade SF, Ederer V, Burgard P, et al.

    Orphanet journal of rare diseases 2021; (16(1)):371 doi:10.1186/s13023-021-02006-w.

    PMID: 34479584
  11. 11

    A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.

    Zhou J, Waskowicz LR, Lim A, et al.

    Thyroid : official journal of the American Thyroid Association 2019; (29(8)):1158-1167 doi:10.1089/thy.2019.0007.

    PMID: 31337282
  12. 12

    Efficacious genome editing in infant mice with glycogen storage disease type Ia.

    Arnson B, Ilich E, von Beck T, et al.

    JCI insight 2025; (10(18)).

    PMID: 40762955
  13. 13

    Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib.

    Zhang Y, Sun H, Wan N

    The Journal of international medical research 2019; (47(12)):5996-6003 doi:10.1177/0300060519867819.

    PMID: 31617422
  14. 14

    Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients.

    Aoun B, Sanjad S, Degheili JA, et al.

    Frontiers in pediatrics 2020; (8()):591 doi:10.3389/fped.2020.00591.

    PMID: 33042926
  15. 15

    Mutational analysis and clinical investigations of medically diagnosed GSD 1a patients from Pakistan.

    Gul B, Firasat S, Shan T, et al.

    PloS one 2023; (18(11)):e0288965 doi:10.1371/journal.pone.0288965.

    PMID: 38033126
  16. 16

    [Advances on the management of renal lesion in glycogen storage disease type I].

    Wu WC, Wang JS

    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2021; (29(1)):75-78 doi:10.3760/cma.j.cn501113-20201230-00687.

    PMID: 33541027
  17. 17

    Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges.

    Schumann A, Garbade SF, Beblo S, et al.

    Molecular genetics and metabolism 2025; (144(3)):109054 doi:10.1016/j.ymgme.2025.109054.

    PMID: 39954548
  18. 18

    Molecular diagnosis of glycogen storage disease type I: a review.

    Beyzaei Z, Geramizadeh B

    EXCLI journal 2019; (18()):30-46.

    PMID: 30956637

This page provides educational information about Glycogen Storage Disease Type I (GSD I). It does not replace professional medical advice from your child's metabolic specialist or care team.

Get notified when new evidence is published on Glycogen storage disease due to glucose-6-phosphatase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.